1. New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension. (29th October 2021) Authors: Stone, John H; Spotswood, Helen; Unizony, Sebastian H; Aringer, Martin; Blockmans, Daniel ; Brouwer, Elisabeth; Cid, Maria C; Dasgupta, Bhaskar; Rech, Juergen; Salvarani, Carlo; Spiera, Robert; Bao, Min Journal: Rheumatology Issue: Volume 61:Number 7(2022) Page Start: 2915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0245 PRESERVATION OF LUNG FUNCTION OBSERVED IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL OF TOCILIZUMAB FOR THE TREATMENT OF EARLY SSC. (June 2019) Authors: Khanna, Dinesh; Lin, Celia J. F.; Goldin, Jonathan; Kim, Grace; Kuwana, Masataka; Allanore, Yannick; Batalov, Anastas; Butrimiene, Irena; Carreira, Patricia; Matucci-Cerinic, Marco; Distler, Oliver; Kaliterna, Dušanka Martinović; Mihai, Carina; Mogensen, Mette; Olesińska, Marzena; Pope, Janet; Ri... Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis. (25th October 2017) Authors: Arnold, Michael B; Khanna, Dinesh; Denton, Christopher P; van Laar, Jacob M; Frech, Tracy M; Anderson, Marina E; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Lakshminarayanan, Santhanam; Allanore, Yannick; Riemekasten, Gabriela; Steen, Virginia; Müller-Ladner, Ulf; Spotswood, Helen; Burke, ... Journal: Rheumatology Issue: Volume 57:Number 1(2018) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Issue 10038 (25th June 2016) Authors: Khanna, Dinesh; Denton, Christopher P; Jahreis, Angelika; van Laar, Jacob M; Frech, Tracy M; Anderson, Marina E; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Lakshminarayanan, Santhanam; Allanore, Yannick; Pope, Janet E; Riemekasten, Gabriela; Steen, Virginia; Müller-Ladner, Ulf; Lafyatis, ... Journal: Lancet Issue: Volume 387:Issue 10038(2016) Page Start: 2630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate). Issue 2 (24th October 2017) Authors: Khanna, Dinesh; Denton, Christopher P; Lin, Celia J F; van Laar, Jacob M; Frech, Tracy M; Anderson, Marina E; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Lakshminarayanan, Santhanam; Allanore, Yannick; Pope, Janet E; Riemekasten, Gabriela; Steen, Virginia; Müller-Ladner, Ulf; Spotswood, He... Journal: Annals of the rheumatic diseases Issue: Volume 77:Issue 2(2018) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10 (October 2020) Authors: Khanna, Dinesh; Lin, Celia J F; Furst, Daniel E; Goldin, Jonathan; Kim, Grace; Kuwana, Masataka; Allanore, Yannick; Matucci-Cerinic, Marco; Distler, Oliver; Shima, Yoshihito; van Laar, Jacob M; Spotswood, Helen; Wagner, Bridget; Siegel, Jeffrey; Jahreis, Angelika; Denton, Christopher P; Lucero, E... Journal: Lancet Issue: Volume 8:Issue 10(2020) Page Start: 963 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗